首页 | 本学科首页   官方微博 | 高级检索  
     

治疗动脉粥样硬化的靶位:A类清道夫受体
引用本文:刘明,洪斌,司书毅. 治疗动脉粥样硬化的靶位:A类清道夫受体[J]. 中国生物工程杂志, 2003, 23(11): 1-6
作者姓名:刘明  洪斌  司书毅
作者单位:中国医学科学院中国协和医科大学医药生物技术研究所 北京 100050
基金项目:国家重大科技专项资助项目 ( 2 0 0 2AA2Z3 43D)
摘    要:动脉粥样硬化性心血管疾病是危害人类健康的常见疾病之一。A类清道夫受体是动脉粥样硬化发生和发展过程中的主要参与者之一,介导巨噬细胞内吞修饰的低密度脂蛋白,形成泡沫细胞,有明显的致动脉粥样硬化作用,是治疗动脉粥样硬化的潜在靶点。另外A类清道夫受体还参与机体的防御过程。重点综述了A类清道夫受体各成员结构及其在动脉粥样硬化中的生理作用和在新药研发方面的应用与展望。

关 键 词:清道夫受体  动脉粥样硬化  MSR1  MARCO  SR-CL  
修稿时间:2003-08-25

A Therapeutic Target for Atherosclerosis: Scavenger Receptor A
Liu Ming Hong Bin Si Shuyi. A Therapeutic Target for Atherosclerosis: Scavenger Receptor A[J]. China Biotechnology, 2003, 23(11): 1-6
Authors:Liu Ming Hong Bin Si Shuyi
Abstract:Cardiovascular disease is the number one killer in modern society and atherosclerosis is the major cause of this disease.Scavenger Receptor A (SR A) mediates the unlimited influx of modified low density lipoprotein (mLDL) into the macrophages and eventually leads to the formation of lipid filled foam cell,which is the hallmark of fatty streaks and atherosclerotic plaques in human disease and in animal models of atherosclerosis.The deletion of the MSR1 gene in the mouse has shown that this receptor serves a pro atherogenic function under hyperlipidemic conditions.Those above make SR A a potential target for atherosclerosis.In addition,SR A has been shown to be important in host defense. The structure of each member of class A(SR|A), their function in atherosclerosis and their application, potential development in new drug screening were focused on.
Keywords:Scavenger receptor Atherosclerosis MSR1 MARCO SR CL
本文献已被 CNKI 维普 万方数据 等数据库收录!
点击此处可从《中国生物工程杂志》浏览原始摘要信息
点击此处可从《中国生物工程杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号